Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 11 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Context Therapeutics Inc. | 815,000 | reported | 19 Feb 2026 | tx 29+4,459,172−1,594,388 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Feb 2026 | GRANT_AWARD | Context Therapeutics Inc. | 815,000 | 0.00 USD | deriv |
| 09 Jun 2025 | PURCHASE | Context Therapeutics Inc. | 100,000 | 0.70 USD | first after silence |
| 13 Feb 2025 | GRANT_AWARD | Context Therapeutics Inc. | 802,700 | 0.00 USD | deriv |
| 21 Mar 2024 | GRANT_AWARD | Context Therapeutics Inc. | 291,402 | 0.00 USD | deriv |
| 21 Feb 2023 | PURCHASE | Context Therapeutics Inc. | 5,823 | 0.84 USD | |
| 13 Feb 2023 | GRANT_AWARD | Context Therapeutics Inc. | 287,544 | 0.00 USD | deriv |
| 13 Feb 2023 | PURCHASE | Context Therapeutics Inc. | 5,606 | 0.87 USD | |
| 06 Feb 2023 | PURCHASE | Context Therapeutics Inc. | 5,040 | 0.97 USD | |
| 30 Jan 2023 | PURCHASE | Context Therapeutics Inc. | 7,027 | 0.70 USD | |
| 23 Jan 2023 | PURCHASE | Context Therapeutics Inc. | 6,839 | 0.72 USD | |
| 17 Jan 2023 | PURCHASE | Context Therapeutics Inc. | 6,783 | 0.74 USD | |
| 16 Dec 2022 | PURCHASE | Context Therapeutics Inc. | 20,000 | 0.74 USD | |
| 19 Aug 2022 | PURCHASE | Context Therapeutics Inc. | 13,000 | 1.85 USD | |
| 25 Feb 2022 | GRANT_AWARD | Context Therapeutics Inc. | 254,300 | 0.00 USD | deriv |
| 16 Dec 2021 | PURCHASE | Context Therapeutics Inc. | 13,000 | 3.22 USD | |
| 22 Oct 2021 | CONVERSION | Context Therapeutics Inc. | 210,722 | — | |
| 22 Oct 2021 | PURCHASE | Context Therapeutics Inc. | 10,000 | 5.00 USD | |
| 22 Oct 2021 | EXERCISE | Context Therapeutics Inc. | 52,680 | 7.14 USD | |
| 22 Oct 2021 | CONVERSION | Context Therapeutics Inc. | 586,476 | — | |
| 22 Oct 2021 | CONVERSION | Context Therapeutics Inc. | 210,722 | — | deriv |
| 22 Oct 2021 | CONVERSION | Context Therapeutics Inc. | 586,476 | — | deriv |
| 22 Oct 2021 | EXERCISE | Context Therapeutics Inc. | 52,680 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 09 Jun 2025.